[
  {
    "ts": null,
    "headline": "Charles River Laboratories to Sell Certain European Assets, Businesses; Full-Year 2026 Guidance Updated",
    "summary": "Charles River Laboratories International (CRL) said Wednesday that it has agreed to sell five Europe",
    "url": "https://finnhub.io/api/news?id=df3db83a057d766c221d27242d50bbf00841d761b982e92af6a90e41c70700ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772024935,
      "headline": "Charles River Laboratories to Sell Certain European Assets, Businesses; Full-Year 2026 Guidance Updated",
      "id": 139207772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River Laboratories International (CRL) said Wednesday that it has agreed to sell five Europe",
      "url": "https://finnhub.io/api/news?id=df3db83a057d766c221d27242d50bbf00841d761b982e92af6a90e41c70700ea"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities",
    "summary": "RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.",
    "url": "https://finnhub.io/api/news?id=590558db8c21161dead349b4fa1f0eec7df86271dcf6e47cd109214211c0d2b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772020800,
      "headline": "IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities",
      "id": 139207773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.",
      "url": "https://finnhub.io/api/news?id=590558db8c21161dead349b4fa1f0eec7df86271dcf6e47cd109214211c0d2b6"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories Provides Update on Planned Divestitures",
    "summary": "WILMINGTON, Mass., February 25, 2026--Charles River Laboratories Provides Update on Planned Divestitures",
    "url": "https://finnhub.io/api/news?id=27ec6cd7332b2866842e63e063055ab513e6c93cfbac6e3be870bac6fd8be5f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772020800,
      "headline": "Charles River Laboratories Provides Update on Planned Divestitures",
      "id": 139207915,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., February 25, 2026--Charles River Laboratories Provides Update on Planned Divestitures",
      "url": "https://finnhub.io/api/news?id=27ec6cd7332b2866842e63e063055ab513e6c93cfbac6e3be870bac6fd8be5f2"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans",
    "summary": "Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shares trade near 52-week lows.",
    "url": "https://finnhub.io/api/news?id=88ca3e6df28fb6a83687b7efe833959b7de0b95c92b607e7704afb3280d5024a",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772013994,
      "headline": "Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans",
      "id": 139209798,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/25/Konskie--Poland---December-15--2024-Char.jpeg?width=2048&height=1536",
      "related": "CRL",
      "source": "Benzinga",
      "summary": "Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shares trade near 52-week lows.",
      "url": "https://finnhub.io/api/news?id=88ca3e6df28fb6a83687b7efe833959b7de0b95c92b607e7704afb3280d5024a"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Raises FY2026 Adj EPS Guidance from $10.70-$11.20 to $10.80-$11.30 vs $10.88 Est",
    "summary": "The Company&#39;s updated 2026 guidance for revenue and non-GAAP earnings per share is as follows:2026 GUIDANCE INCLUDING THE IMPACT OF THE PLANNED DIVESTITURES (1) Revenue growth, reported (prior)At Least Flat to",
    "url": "https://finnhub.io/api/news?id=1a59325a9d994af2ff27a0b6ad942b62b23222918894ec277a9064ebf0d705b9",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772007647,
      "headline": "Charles River Raises FY2026 Adj EPS Guidance from $10.70-$11.20 to $10.80-$11.30 vs $10.88 Est",
      "id": 139209946,
      "image": "",
      "related": "CRL",
      "source": "Benzinga",
      "summary": "The Company&#39;s updated 2026 guidance for revenue and non-GAAP earnings per share is as follows:2026 GUIDANCE INCLUDING THE IMPACT OF THE PLANNED DIVESTITURES (1) Revenue growth, reported (prior)At Least Flat to",
      "url": "https://finnhub.io/api/news?id=1a59325a9d994af2ff27a0b6ad942b62b23222918894ec277a9064ebf0d705b9"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories To Sell Certain European Discovery Services Assets And  CDMO and Cell Solutions Businesses To IQVIA In Separate Transactions",
    "summary": "Charles River Laboratories International, Inc. (NYSE:CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in",
    "url": "https://finnhub.io/api/news?id=8b93e4076f45b1e472ce85885a6932a1a02188960b538bf2c7ae36e9ea87e262",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772006933,
      "headline": "Charles River Laboratories To Sell Certain European Discovery Services Assets And  CDMO and Cell Solutions Businesses To IQVIA In Separate Transactions",
      "id": 139209799,
      "image": "",
      "related": "CRL",
      "source": "Benzinga",
      "summary": "Charles River Laboratories International, Inc. (NYSE:CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in",
      "url": "https://finnhub.io/api/news?id=8b93e4076f45b1e472ce85885a6932a1a02188960b538bf2c7ae36e9ea87e262"
    }
  }
]